Liquid neurotoxin formulation stabilized with tryptophan or tyrosine
AssigneeIpsen Biopharm Ltd.
InventorsAnders JARSTAD, Anna FRIIS, Ulf STAHL, Ann GURELL, Barbro AGREN, Emilia EDSTROM, Andrew PICKETT
Life of this patent
Estimating the term…
Loading patent…
AssigneeIpsen Biopharm Ltd.
InventorsAnders JARSTAD, Anna FRIIS, Ulf STAHL, Ann GURELL, Barbro AGREN, Emilia EDSTROM, Andrew PICKETT
Estimating the term…
The invention relates to stable liquid neurotoxin formulations which are free of animal proteins, comprising a surfactant, an amino acid selected from tryptophan and tyrosine, a buffer comprising sodium, chloride and phosphate ions, which have a pH between 5.5 and 8, and which are stable for 2 months. These compositions are suitable for use in therapy and in particular for administration to a patient to achieve a desired therapeutic or aesthetic effect. The invention also relates to the use of an amino acid selected from tryptophan and tyrosine to protect a proteinaceous neurotoxin from degradation in a liquid composition which is free of animal derived proteins.
A liquid composition comprising a proteinaceous neurotoxin, a surfactant, an amino acid selected from tryptophan and tyrosine, a buffer comprising sodium, chloride and phosphate ions,
Use of an amino acid selected from tryptophan and tyrosine to protect a proteinaceous neurotoxin from degradation in a liquid composition which is free of animal derived proteins.
Dependencies are inferred from the claim text.